![]() |
市場調查報告書
商品編碼
1490757
2024-2028年全球腫瘤消融市場Global Tumor Ablation Market 2024-2028 |
2023-2028年腫瘤消融市場預估為14.328億美元,預測期內複合年成長率為14.62%。
該報告包括對腫瘤消融市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。
它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括人們對微創治療的偏好、對個人化醫療和標靶治療的持續重視以及對門診癌症治療的日益關注。
市場範圍 | |
---|---|
基準年 | 2024年 |
結束年份 | 2028年 |
預測期 | 2024-2028 |
成長動力 | 加速度 |
2024年與前一年同期比較 | 14.42% |
複合年成長率 | 14.62% |
增量 | 1,432.8 百萬美元 |
研究指出,越來越多採用影像導引腫瘤消融是推動未來幾年腫瘤消融市場成長的關鍵因素之一。此外,多模態腫瘤消融方法的開拓以及人工智慧(AI)與腫瘤消融平台的整合將帶來巨大的市場需求。
The tumor ablation market is forecasted to grow by USD 1432.8 mn during 2023-2028, accelerating at a CAGR of 14.62% during the forecast period. The report on the tumor ablation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing preference for minimally invasive procedures, continued emphasis on personalized medicine and targeted therapies, and rising focus on cancer treatment in outpatient settings.
Technavio's tumor ablation market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 14.42% |
CAGR | 14.62% |
Incremental Value | $1432.8mn |
By Type
By Application
By Geographical Landscape
This study identifies the increasing adoption of image-guided tumor ablation as one of the prime reasons driving the tumor ablation market growth during the next few years. Also, development of multimodal tumor ablation approaches and integration of artificial intelligence (AI) into tumor ablation platforms will lead to sizable demand in the market.
The report on the tumor ablation market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tumor ablation market vendors that include Alpinion Medical Systems Co. Ltd., AngioDynamics Inc., Apyx Medical Corp., Bioventus LLC, Boston Scientific Corp., BVM Medical Ltd., EDAP TMS, ForTec Medical, IceCure Medical Ltd., Johnson and Johnson Services Inc., Medtronic Plc, Merit Medical Systems Inc., Mermaid Medical Group, Monteris Medical Corp., Olympus Europa SE and Co. KG, Profound Medical Corp., Smith and Nephew plc, Stryker Corp., TechsoMed Medical Technologies Ltd., Terumo Corp., and Varian Medical Systems Inc.. Also, the tumor ablation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: